NOMIS will extend its support of the Platform for the Discovery of Alzheimer’s Disease Mechanisms and Treatments project, led by Eric Reiman at the Banner Alzheimer’s Institute. The project has revealed many new insights about Alzheimer’s disease since it was launched in 2017.
NOMIS recently awarded the Banner Alzheimer’s Institute a $2 million grant, with an additional $1 million forthcoming upon achievement of certain benchmarks. The funds will allow BAI and its partners to continue their groundbreaking research that began in 2012 in Antioquia, Colombia to find an effective prevention for Alzheimer’s disease.
In collaboration with the University of Antioquia in Colombia, Roche, and the National Institute on Aging, investigators from BAI’s Alzheimer’s Prevention Initiative will be able to continue their study of and support for members of the world’s largest early-onset, autosomal-dominant Alzheimer’s disease kindred. The family in Colombia includes 6,000 descendants from a common ancestor — 1,200 of whom carry a gene that causes them to develop Alzheimer’s disease and become cognitively impaired at the average age of 44.
Continue reading this Banner Alzheimer’s Institute release: Banner Alzheimer’s Institute receives prestigious grant to advance research
